ACQUIRED · 2025
Who Acquired Accolade, Inc.?
Transcarent, Inc. · $621.0M · 2025
The acquisition
Accolade, Inc. (United States and Canada) was acquired by Transcarent, Inc. in 2025 for $621.0M. Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists,.
Accolade, Inc. at time of acquisition
Revenue
$467.5M
EBITDA
$17.5M
Deal value
$621.0M
Own a healthtech business? See what it's worth.
Transcarent, Inc. acquired Accolade, Inc. for $621.0M. Get an M&A-grade EBITDA range and sellability score for your own business, benchmarked against 25,592 real transactions. 2 minutes, no signup.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Similar healthtech acquisitions
- Streamline Health · acquired by MDaudit in 2025 · $37.0M
- iCAD, Inc. · acquired by RadNet, Inc. in 2025 · $86.0M
- Model N · acquired by Vista Equity Partners in 2024 · $1.25B
- Sharecare, Inc. · acquired by Altaris in 2024 · $419.0M
- Benefitfocus · acquired by Voya Financial in 2023 · $570.0M
More on healthtech valuations
- Value a healthtech· run the calculator
- Healthtech median multiples· real-deal benchmarks
- Who buys healthtech businesses?· active buyers
- Who acquired Accolade, Inc.?· buyer profile
Sourced from SEC Fairness Opinion. Primary source. Full deal page
Citation: ExitValue.ai. (2025). Accolade, Inc. acquired by Transcarent, Inc.. https://exitvalue.ai/acquired/accolade-inc